Abstract
The majority of global cardiovascular disease burden occurs in low- and middle-income countries (LMIC) and indigenous populations. Although common diseases, such as ischaemic heart disease, cause significant burden, there are also neglected diseases. Forgotten by many, these diseases—including rheumatic heart disease, endomyocardial fibrosis and Chagas cardiomyopathy—continue to take a tremendous toll on a large proportion of the world's population. Whilst the technology of echocardiography continues to evolve in many high-income countries, low resource countries are working out how to make this vital tool available and affordable for the most remote and poorest populations. This paper aims to highlight the neglected cardiovascular diseases and their echocardiographic features. It also highlights the latest research in relation to portable echocardiography, task shifting and disease screening. The authors make recommendations in relation to future directions, including making echocardiography an affordable and accessible tool for all.
| Original language | English |
|---|---|
| Pages (from-to) | 1427-1435 |
| Number of pages | 9 |
| Journal | Heart Lung and Circulation |
| Volume | 28 |
| Issue number | 9 |
| Early online date | 10 Jun 2019 |
| DOIs | |
| Publication status | Published - Sep 2019 |
Fingerprint
Cite this
}
Echocardiography in Indigenous Populations and Resource Poor Settings. / Marangou, James; Beaton, Andrea; Aliku, Twalib Olega; Nunes, Maria Carmo P.; Kangaharan, Nadarajah; Reményi, Bo.
In: Heart Lung and Circulation, Vol. 28, No. 9, 09.2019, p. 1427-1435.Research output: Contribution to journal › Review article › Research › peer-review
TY - JOUR
T1 - Echocardiography in Indigenous Populations and Resource Poor Settings
AU - Marangou, James
AU - Beaton, Andrea
AU - Aliku, Twalib Olega
AU - Nunes, Maria Carmo P.
AU - Kangaharan, Nadarajah
AU - Reményi, Bo
PY - 2019/9
Y1 - 2019/9
N2 - The majority of global cardiovascular disease burden occurs in low- and middle-income countries (LMIC) and indigenous populations. Although common diseases, such as ischaemic heart disease, cause significant burden, there are also neglected diseases. Forgotten by many, these diseases—including rheumatic heart disease, endomyocardial fibrosis and Chagas cardiomyopathy—continue to take a tremendous toll on a large proportion of the world's population. Whilst the technology of echocardiography continues to evolve in many high-income countries, low resource countries are working out how to make this vital tool available and affordable for the most remote and poorest populations. This paper aims to highlight the neglected cardiovascular diseases and their echocardiographic features. It also highlights the latest research in relation to portable echocardiography, task shifting and disease screening. The authors make recommendations in relation to future directions, including making echocardiography an affordable and accessible tool for all.
AB - The majority of global cardiovascular disease burden occurs in low- and middle-income countries (LMIC) and indigenous populations. Although common diseases, such as ischaemic heart disease, cause significant burden, there are also neglected diseases. Forgotten by many, these diseases—including rheumatic heart disease, endomyocardial fibrosis and Chagas cardiomyopathy—continue to take a tremendous toll on a large proportion of the world's population. Whilst the technology of echocardiography continues to evolve in many high-income countries, low resource countries are working out how to make this vital tool available and affordable for the most remote and poorest populations. This paper aims to highlight the neglected cardiovascular diseases and their echocardiographic features. It also highlights the latest research in relation to portable echocardiography, task shifting and disease screening. The authors make recommendations in relation to future directions, including making echocardiography an affordable and accessible tool for all.
KW - Chagas cardiomyopathy
KW - Echocardiography
KW - Endomyocardial fibrosis
KW - Indigenous
KW - Rheumatic heart disease
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85068171812&partnerID=8YFLogxK
U2 - 10.1016/j.hlc.2019.05.176
DO - 10.1016/j.hlc.2019.05.176
M3 - Review article
VL - 28
SP - 1427
EP - 1435
JO - Heart Lung and Circulation
JF - Heart Lung and Circulation
SN - 1444-2892
IS - 9
ER -